Results for Unaudited Financial Results for September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mardia Samyoung Capillary Tubes reported unaudited results for Q2 FY26 (quarter ended Sep 30, 2025), showing revenue of Rs 40.88 lakhs versus just Rs 0.58 lakhs in the year-ago quarter, a sharp jump from a very low base. For the half year ended Sep 30, 2025, revenue stood at Rs 40.88 lakhs versus Rs 12.33 lakhs in H1 FY25. However, the company posted a loss before tax of Rs 142.56 lakhs for the half year (vs a loss of Rs 21.16 lakhs in H1 FY25), with loss per share of Rs 2.05. Net worth remains weak with negative other equity of Rs 154.11 lakhs, and operating cash flow was negative at Rs 3.48 lakhs. The statutory auditor (S K Bhavsar & Co.) issued an unmodified limited review opinion with an Emphasis of Matter note flagging that trade receivables, trade payables, and loans/advances balances are pending independent verification and reconciliation.
Short-term shareholders should note the widened half-yearly loss, negative reserves, and the auditor's emphasis of matter on unverified balances, all of which raise concerns about financial reporting quality and going concern, despite the headline revenue bounce.